2011 - 10th Meeting - IHCTAS


This page contains exclusive content for the member of the following sections: TTS, IHCTAS. Log in to view.

Posters

2.14 - BONE QUALITY EVALUATION IN ALLOGRAFT HAND TRANSPLANT

Presenter: Christophe, Rizzo, Lyon, France
Authors: Christophe Rizzo, Vincent Guigal, Jean Baptiste Pialat, Nicolas Vilayphiou, Emmanuel Deshayes, Aram Gazarian

BONE QUALITY EVALUATION IN ALLOGRAFT HAND TRANSPLANT

Christophe Rizzo1, Vincent Guigal1, Jean Baptiste Pialat2, Nicolas Vilayphiou3, Emmanuel Deshayes4, Aram Gazarian1,5.

1Département de Chirurgie de la Main, Clinique du Parc; 2Service de Radiologie, Hôpital Edouard Herriot; 3Inserm 831, Hôpital Edouard Herriot; 4Service de Médecine Nucléaire, Hôpital Edouard Herriot; 5Service de Chirurgie de la Transplantation, Hôpital Edouard Herriot, Lyon, France.

Five bilateral forearms allograft have been performed between January 2000 and July 2009 in Lyon (France). The first four patients (three males, one female) have been the subject of an assessment of the bone quality of those allografts. The techniques selected for this study were : radioclinical analysis, bone scintigraphy, MRI, bone densitometry and High Resolution peripheral Quantitative Computer Tomography (HR-PQCT). On the clinical, radiological and scingraphical aspects, donor bone integration in hands allograft are good on a macroscopic point of view considering the healing and the general reaction of the bone in situation of fractures, infection and growth. The scintigraphy does not show important variations compared to the one we can observe on contact with osteosynthesis material or during bone autografts. MRI found neither focal nor periosteal anomaly on grafted bone. The bone densitometry did not show significant difference with secondary osteoporosis one can observe in other grafted patients under immunosuppressive treatment. The HR-PQCT showed for the three males patients, a higher loss in volumetric density, for grafted bone than in the recipient patient control skeleton. Due to the small number of patients in this series and the discrepancies in follow-up duration, the present datas have to be confirmed with further studies.


Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.

Social

Contact

Staff Directory
+1-514-874-1717
info@tts.org

Address

The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada